MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 192 filers reported holding MYRIAD GENETICS INC in Q3 2022. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,736,651 | -30.8% | 108,270 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $2,509,699 | -0.2% | 108,270 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $2,515,112 | +44.2% | 108,270 | -9.9% | 0.00% | 0.0% |
Q4 2022 | $1,744,523 | -22.8% | 120,229 | +1.5% | 0.00% | 0.0% |
Q3 2022 | $2,259,000 | +1.7% | 118,399 | -3.1% | 0.00% | 0.0% |
Q2 2022 | $2,221,000 | -25.3% | 122,233 | +3.5% | 0.00% | 0.0% |
Q1 2022 | $2,975,000 | -8.5% | 118,071 | +0.3% | 0.00% | 0.0% |
Q4 2021 | $3,250,000 | -14.2% | 117,757 | +0.4% | 0.00% | 0.0% |
Q3 2021 | $3,789,000 | +2.2% | 117,330 | -3.2% | 0.00% | 0.0% |
Q2 2021 | $3,706,000 | +6.1% | 121,200 | +5.6% | 0.00% | -50.0% |
Q1 2021 | $3,494,000 | +56.3% | 114,730 | +1.5% | 0.00% | +100.0% |
Q4 2020 | $2,235,000 | +51.6% | 113,020 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,474,000 | +15.2% | 113,020 | +0.2% | 0.00% | 0.0% |
Q2 2020 | $1,280,000 | -25.3% | 112,850 | -5.8% | 0.00% | 0.0% |
Q1 2020 | $1,714,000 | -48.1% | 119,800 | -1.2% | 0.00% | -50.0% |
Q4 2019 | $3,302,000 | -34.5% | 121,260 | -31.1% | 0.00% | -33.3% |
Q3 2019 | $5,038,000 | -11.3% | 175,980 | -13.9% | 0.00% | -25.0% |
Q2 2019 | $5,679,000 | -2.0% | 204,420 | +17.1% | 0.00% | 0.0% |
Q1 2019 | $5,797,000 | +15.0% | 174,620 | +0.7% | 0.00% | 0.0% |
Q4 2018 | $5,041,000 | -39.0% | 173,420 | -3.5% | 0.00% | -20.0% |
Q3 2018 | $8,265,000 | +16.0% | 179,669 | -5.8% | 0.01% | 0.0% |
Q2 2018 | $7,126,000 | +44.2% | 190,678 | +14.0% | 0.01% | +25.0% |
Q1 2018 | $4,941,000 | -12.2% | 167,220 | +2.0% | 0.00% | 0.0% |
Q4 2017 | $5,630,000 | -5.1% | 163,930 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $5,931,000 | +42.1% | 163,930 | +1.5% | 0.00% | +33.3% |
Q2 2017 | $4,173,000 | +118.4% | 161,510 | +62.3% | 0.00% | +50.0% |
Q1 2017 | $1,911,000 | +7.5% | 99,510 | -6.7% | 0.00% | +100.0% |
Q4 2016 | $1,778,000 | -34.3% | 106,660 | -18.8% | 0.00% | -50.0% |
Q3 2016 | $2,705,000 | -36.8% | 131,414 | -6.1% | 0.00% | -50.0% |
Q2 2016 | $4,282,000 | -14.0% | 139,924 | +5.2% | 0.00% | 0.0% |
Q1 2016 | $4,979,000 | -5.2% | 133,029 | +9.3% | 0.00% | 0.0% |
Q4 2015 | $5,252,000 | +10.5% | 121,690 | -4.1% | 0.00% | 0.0% |
Q3 2015 | $4,755,000 | +10.1% | 126,860 | -0.1% | 0.00% | 0.0% |
Q2 2015 | $4,318,000 | +148.0% | 127,050 | +158.3% | 0.00% | +300.0% |
Q1 2015 | $1,741,000 | +2.3% | 49,184 | -1.6% | 0.00% | 0.0% |
Q4 2014 | $1,702,000 | -19.5% | 49,984 | -8.8% | 0.00% | -50.0% |
Q3 2014 | $2,113,000 | -0.3% | 54,784 | +0.6% | 0.00% | 0.0% |
Q2 2014 | $2,119,000 | +12.6% | 54,434 | -1.1% | 0.00% | 0.0% |
Q1 2014 | $1,882,000 | +75.2% | 55,031 | +7.5% | 0.00% | +100.0% |
Q4 2013 | $1,074,000 | -13.7% | 51,210 | -3.3% | 0.00% | 0.0% |
Q3 2013 | $1,244,000 | -11.6% | 52,940 | +1.1% | 0.00% | 0.0% |
Q2 2013 | $1,407,000 | – | 52,345 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |